INITIO Trial International Co-ordinating Committee, Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A, Meiffredy V, Salzberger B.
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial. Lancet. 2006; 368:287-298
INSIGHT-ESPRIT Study Group and SILCAAT Scientific Committee,.
Interleukin-2 Therapy in Patients with HIV Infection. The New England Journal of Medicine. 2009; 361:1548-1559
International Artemisinin Group.
Artesunate combinations for treating uncomplicated malaria: An individual-patient data meta-analysis. Lancet. 2004; 363:9-17